ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,236Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 890

$1.58M Total Retail Price of All Prescriptions

Rank: 6 out of 890

721 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 721 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

17% of this provider’s 721 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 16,366 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LISINOPRIL 820 582 1 4
AMLODIPINE BESYLATE 705 609 2 1
SIMVASTATIN 620 480 3 5
HYDROCHLOROTHIAZIDE 518 343 4 9
FUROSEMIDE 493 388 5 7
LEVOTHYROXINE SODIUM 448 349 6 2
METFORMIN HCL 423 256 7 6
CARVEDILOL 397 319 8 22
METOPROLOL TARTRATE 391 266 9 15
NAMENDA 358 327 10 36
TRAMADOL HCL 343 278 11 16
RISPERIDONE 334 187 12 78
OMEPRAZOLE 331 266 13 8
NEXIUM 317 228 14 14
HYDROCODONE-ACETAMINOPHEN 316 195 S3 15 3
DONEPEZIL HCL 315 281 16 30
LANTUS 312 216 17 50
PRAVASTATIN SODIUM 305 208 18 10
CYMBALTA 292 193 19 45
POTASSIUM CHLORIDE 286 191 20 11
GABAPENTIN 252 187 21 12
PANTOPRAZOLE SODIUM 227 160 22 34
CLOPIDOGREL 216 176 23 28
NIFEDIPINE ER 210 140 24 75
ESCITALOPRAM OXALATE 205 143 25 51
DIVALPROEX SODIUM 199 95 26 126
LYRICA 199 115 26 71
LEVETIRACETAM 196 68 28 137
CLONIDINE HCL 185 144 29 35
DIOVAN 171 126 30 33
QUETIAPINE FUMARATE 169 99 31 73
TAMSULOSIN HCL 168 131 32 32
TRAZODONE HCL 163 112 33 40
CITALOPRAM HBR 162 104 34 20
METOPROLOL SUCCINATE 161 71 35 17
ATORVASTATIN CALCIUM 161 94 35 13
PLAVIX 158 128 37 42
CIPROFLOXACIN HCL 154 120 38 58
AGGRENOX 154 143 38 219
LACTULOSE 152 119 40 112
WARFARIN SODIUM 150 111 41 24
KLOR-CON M20 149 122 42 72
PHENYTOIN SODIUM EXTENDED 149 76 42 111
ISOSORBIDE MONONITRATE ER 148 123 44 60
SERTRALINE HCL 146 77 45 26
CRESTOR 143 93 46 25
MELOXICAM 138 86 47 18
EXELON 138 138 47 113
FAMOTIDINE 136 65 49 90
HYDRALAZINE HCL 135 108 50 100
PREDNISONE 133 88 51 47
ATENOLOL 126 104 52 23
ENALAPRIL MALEATE 121 78 53 56
NOVOLIN R 121 98 53 153
BUMETANIDE 118 79 55 134
POLYETHYLENE GLYCOL 3350 118 85 55 67
LABETALOL HCL 116 85 57 208
BACLOFEN 112 28 58 161
CYCLOBENZAPRINE HCL 107 32 R 59 64
GLIMEPIRIDE 105 66 60 27
PROMETHAZINE HCL 101 42 R 61 104
AMITIZA 100 82 62 210
MIRTAZAPINE 100 57 62 82
ZOLPIDEM TARTRATE 95 51 64 19
DETROL LA 95 48 64 164
LOVASTATIN 94 84 66 46
DOXAZOSIN MESYLATE 92 83 67 70
LOSARTAN POTASSIUM 90 65 68 29
HALOPERIDOL 89 68 69 286
COLCRYS 89 85 69 150
IBUPROFEN 87 20 71 101
SEROQUEL XR 87 43 71 240
NOVOLOG 86 63 73 178
ACETAMINOPHEN-CODEINE 86 71 S3 73 124
SEROQUEL 84 43 75 167
CARBIDOPA-LEVODOPA 81 75 76 136
AMLODIPINE BESYLATE-BENAZEPRIL 78 55 77 41
NIFEDICAL XL 77 63 78 253
GLIPIZIDE 76 60 79 62
LIPITOR 74 44 80 77
FINASTERIDE 71 62 81 108
METOCLOPRAMIDE HCL 71 49 81 125
DIOVAN HCT 69 55 83 48
CLONIDINE 68 51 84 242
PAROXETINE HCL 68 54 84 68
BISOPROLOL-HYDROCHLOROTHIAZIDE 68 58 84 122
DIGOXIN 66 35 87 65
FOSINOPRIL SODIUM 65 39 88 184
HYDROXYZINE PAMOATE 65 18 R 88 205
INSULIN SYRINGE 65 44 88 99
NICARDIPINE HCL 63 40 10 91 408
LEXAPRO 62 39 92 186
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 40 92 21
SINGULAIR 61 42 94 79
LOSARTAN-HYDROCHLOROTHIAZIDE 60 41 95 57
TRIAMCINOLONE ACETONIDE 60 46 95 160
JANUVIA 59 35 97 59
FENTANYL 59 32 S2 97 151
SYMBICORT 58 41 99 174
AMPICILLIN TRIHYDRATE 57 36 100 422
NAPROXEN 57 36 100 84
ALENDRONATE SODIUM 56 33 102 38
ABILIFY 55 34 103 172
FLUOXETINE HCL 55 33 103 63
DILTIAZEM HCL 55 46 103 235
RANITIDINE HCL 55 34 103 49
VESICARE 54 42 107 188
METHYLDOPA 54 43 R 107 337
NIFEDIAC CC 54 49 107 343
MEGESTROL ACETATE 53 46 R 110 92
NABUMETONE 53 31 110 143
FLUTICASONE PROPIONATE 52 33 112 39
NITROFURANTOIN MONO-MACRO 52 47 112 181
SPIRONOLACTONE 51 46 114 85
BENICAR 50 49 115 180
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.